{"schema":"sb.node.v1","id":"sb:e/1ccaf7a7b68e32af55cbc6a4","kind":"entity","label":{"text":"fda","locale":"en"},"identity":{"anchor":"label:en:fda","strength":"label"},"asOf":{"knowledgeCutoff":"2026-10-24T23:28:52.671179+00:00","releaseId":"sb-e60ae6b07254","snapshot":"deploy 2a03787f2794034027f8ee87fb09135959132514"},"lens":{"kind":"public"},"build":{"plane":"projected","builtFrom":["entity_graph.slim.json","entity_receipts (deploy asset)","event_graph.json","truth_records (deploy asset)","corroborated_record.json"],"rule":"node-projection.entity@v1"},"standing":{"evidence":{"supporting":2564,"separatePublishers":228,"basis":"documents that mention the subject and the outlets that carried them; a mention is evidence the referent is in use, not evidence about any claim","receiptsOnTopic":{"state":"measured","share":0.525,"named":1346,"of":2564,"basis":"documents whose own title or summary lead names the subject, over every counted document that mentions it anywhere (the entity graph's measurement); receipts are drawn only from rows whose own title or URL names the subject (the entity graph's subject gate)"}},"admission":{"state":"canonical","kind":"legacy","kindBasis":"seed","reason":"entity graph provenance 'curated'; part of the hand-written seed vocabulary that predates machine promotion; no receipt exists","policy":"promotion (seed vocabulary; no receipt)"},"disposition":{"state":"served","reason":"public record"},"validity":{"from":"2026-04-06","to":"2026-10-23","basis":"first and last day we saw it mentioned; not the subject's own lifetime"},"measurement":{"state":"partial","blind":["assertion coverage 0.354: about 65% of mentions carry no typed assertion"]}},"dimensions":{"domains":["pharma-regulatory","biotech_pharma"],"activeDays":155,"assertions":{"regulatory-approval":880,"military-action":9,"utterance":8,"election":8,"legal-ruling":2,"meeting-visit":1}},"up":[],"upNote":"An entity is a root: it is contained by nothing. Pan out by following R.","children":{"count":8,"byKind":{"observation":8},"withheld":{"state":"withheld","count":4,"reason":"4 receipts withheld: no source link (the same rule the topic record applies)"},"items":[{"id":"sb:o/08546ae3bd436d3b6d1c9a3b","kind":"observation","label":"Medical Device Network · 2026-10-23 · FDA grants breakthrough device status to Teleflex’s coronary scaffold","url":"https://www.medicaldevice-network.com/news/fda-breakthrough-teleflexs-coronary-scaffold/","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/156f194fcdf97d6f78667f09","kind":"observation","label":"PR Newswire · 2026-10-23 · Coreline Soft Receives U.S. FDA 510(k) Clearance for AVIEW Aorta Metrics, Expanding Its Chest CT AI Portfolio in the U.S.","url":"https://www.prnewswire.com/news-releases/coreline-soft-receives-us-fda-510k-clearance-for-aview-aorta-metrics-expanding-its-chest-ct-ai-portfolio-in-the-us-302916220.html","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/9f152b5dc84ef1ccc02c6723","kind":"observation","label":"India Today Economy · 2026-10-23 · Centre hijacking powers: Maharashtra FDA takes FSSAI to HC over food safety norms","url":"https://www.indiatoday.in/india/law-news/story/maharashtra-fda-accuses-centre-of-hijacking-powers-takes-fssai-to-bombay-high-court-over-food-safety-enforcement-norms-3023896-2026-10-23?utm_source=rss","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/be4228cac0e530b70e491a52","kind":"observation","label":"STAT News · 2026-10-22 · STAT+: Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction","url":"https://www.statnews.com/2026/10/22/glp-1-drugs-substance-use-disorder-telehealth-off-label-prescription/?utm_campaign=rss","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/f5f775d7ac5eff0fb27c23f5","kind":"observation","label":"STAT News · 2026-10-22 · STAT+: FDA finalizes its guidance on apps related to drugs, pharma rejoices","url":"https://www.statnews.com/2026/10/22/fda-pdurs-guidance-dtx-telehealth-glp1-addiction-health-tech/?utm_campaign=rss","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/672a4291fd0088c885393883","kind":"observation","label":"Clinical Trials Arena · 2026-10-22 · Lynch’s rhPDGF-BB IND secures FDA clearance for Phase II trial","url":"https://www.clinicaltrialsarena.com/news/lynchs-rhpdgf-bb-ind-fda-clearance/","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/4e7944058e0297a6393760ea","kind":"observation","label":"The Hindu · 2026-10-22 · FDA suspends eight Mumbai eateries, seizes 38 tonnes of food stock across Maharashtra","url":"https://www.thehindu.com/news/national/maharashtra/fda-suspends-eight-mumbai-eateries-seizes-38-tonnes-of-food-stock-across-maharashtra/article71612725.ece","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}},{"id":"sb:o/efda47d714da1df8c8b0d851","kind":"observation","label":"Fierce Pharma · 2026-10-22 · FDA rebukes Baxter over 'repeated' production stumbles in new warning letter","url":"https://www.fiercepharma.com/manufacturing/fda-rebukes-baxter-warning-letter-ongoing-production-problems","match":{"surface":"title","basis":"admitted by the entity graph's subject gate (title or URL); the headline names the subject as whole words (the door's on-topic test)"}}],"cursor":null,"order":"newest first; we keep the 8 newest receipts for this entity whose own title or URL (the entity graph's subject gate) names it; each says which in match. Its other observations are counted in standing.evidence.supporting but are not addressable in v1"},"relations":{"count":22,"byKind":{"claim":12,"co-mentioned":10},"items":[{"id":"sb:p/e216ef2b42adb74b00ad06f6","kind":"claim","label":"FDA solidifies stance on mobile apps, software used with prescription drugs in final guidance — corroborated","role":"named-in","relationKind":"claim","members":1},{"id":"sb:p/ba2dd8d434799cbe638304cb","kind":"claim","label":"FDA Approves Immunotherapy That May Allow Certain Patients with Rectal Cancer to Avoid Chemotherapy, Radiation and Surgery — reported by two","role":"named-in","relationKind":"claim","members":1},{"id":"sb:p/470a13430390d8d25ea697b2","kind":"claim","label":"FDA grants traditional approval for pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph for unresectable or metastatic TMB-H solid tumors with updated indication — corroborated","role":"named-in","relationKind":"claim","members":1},{"id":"sb:p/39fe3816dfb56c66dc830a17","kind":"claim","label":"FDA grants accelerated approval to dostarlimab for locally advanced rectal cancer — corroborated","role":"named-in","relationKind":"claim","members":1},{"id":"sb:p/b3f1738ac1eaa132f1e2d9df","kind":"claim","label":"Samsung Bioepis wins FDA Fast Track for 1st anticancer drug candidate — reported by two","role":"named-in","relationKind":"claim","members":1},{"id":"sb:p/8cef58054db9e318179299c7","kind":"claim","label":"FDA suspends eight Mumbai eateries, seizes 38 tonnes of food stock across Maharashtra — reported by two","role":"named-in","relationKind":"claim","members":1},{"id":"sb:p/f6ea3232cc8b43a658b37ac9","kind":"claim","label":"FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women — single source","role":"named-in","relationKind":"claim","members":1},{"id":"sb:p/ea6bc4d75e924bc76af41df2","kind":"claim","label":"fda concerns unapproved glp-1 drugs weight loss 2026 — could not check","role":"named-in","relationKind":"claim","members":1},{"id":"sb:p/ed930d0912f664622393095e","kind":"claim","label":"Haemonetics Announces FDA Approval of PerQseal® Elite Vascular Closure System — single source","role":"named-in","relationKind":"claim","members":1},{"id":"sb:p/ed5b543a99d01873cb439583","kind":"claim","label":"STAT+: FDA finalizes its guidance on apps related to drugs, pharma rejoices — single source","role":"named-in","relationKind":"claim","members":1}],"cursor":"c1.eyJpZCI6InNiOmUvMWNjYWY3YTdiNjhlMzJhZjU1Y2JjNmE0IiwibCI6InJlbGF0aW9ucyIsIm8iOjEwLCJrIjpudWxsLCJhIjoiMjAyNi0xMC0yNFQyMzoyODo1Mi42NzExNzkrMDA6MDAifQ","order":"situations first, then claims (the subject's own maintained record, then site-wide corroborated clusters; each label ends with its standing), then co-mentions by shared documents, descending. Co-mentions are the ten strongest the entity graph keeps per entity"},"edge":{"state":"continues"},"links":{"rest":"/api/v1/node/e/1ccaf7a7b68e32af55cbc6a4","mcp":"traverse {\"id\":\"sb:e/1ccaf7a7b68e32af55cbc6a4\"}","page":"/entity/fda/"},"limits":{"levelsPerCall":1,"pageSize":10,"maxPageSize":50,"membersMax":50,"statement":"One level per call: depth is 1 and only 1, and there is no whole-graph dump. pageSize 1-50 (default 10); a page limit is a cursor, never an edge. Members are listed up to 50. At most 60 traverse calls a minute per caller (runaway-loop protection, not a meter). One knowledge cutoff is served: the deploy's."},"actions":[{"verb":"unfold","lit":true,"effect":"read","layer":"free-record","call":"traverse {\"id\":\"sb:e/1ccaf7a7b68e32af55cbc6a4\",\"level\":\"children\"}"},{"verb":"fold","lit":true,"effect":"read","layer":"free-record","call":"traverse {\"id\":\"sb:e/1ccaf7a7b68e32af55cbc6a4\"}"},{"verb":"panOut","lit":false,"effect":"read","layer":"free-record","reason":"An entity is a root: it is contained by nothing. Pan out by following R."},{"verb":"follow","lit":true,"effect":"read","layer":"free-record","call":"traverse {\"id\":\"sb:e/1ccaf7a7b68e32af55cbc6a4\",\"level\":\"relations\"}"},{"verb":"receipts","lit":false,"effect":"read","layer":"free-record","reason":"receipts are the observations below this node; unfold to reach them"},{"verb":"edge","lit":true,"effect":"read","layer":"free-record","call":"traverse {\"id\":\"sb:e/1ccaf7a7b68e32af55cbc6a4\"}"},{"verb":"asOf","lit":false,"effect":"read","layer":"free-record","reason":"v1 serves one knowledge cutoff, this deploy's; walking an earlier cutoff needs retained history, which v1 does not keep"},{"verb":"switchObserver","lit":false,"effect":"read","layer":"free-record","reason":"the public record is the same for every observer; traversal through a Watch's lens is not served in v1"},{"verb":"readOriginal","lit":false,"effect":"read","layer":"free-record","reason":"no translation is applied on this node; every label is the source's own text"},{"verb":"save","lit":false,"effect":"watch-declaration","layer":"watch","reason":"saving applies to a configured Watch; configure one around this node first (free), then save it"},{"verb":"deliver","lit":false,"effect":"watch-declaration","layer":"watch","reason":"delivery applies to a saved Watch"},{"verb":"format","lit":false,"effect":"watch-declaration","layer":"watch","reason":"output format applies to a saved Watch"},{"verb":"deltaR","lit":false,"effect":"read","layer":"watch","reason":"Delta R needs a saved Watch with a previous reading"},{"verb":"read","lit":false,"effect":"read","layer":"one-time-read","reason":"one-time Reads are not offered through this door; use ask"}]}